Resources>Blog>Pros and Cons of Using Monoclonal Antibodies

Pros and Cons of Using Monoclonal Antibodies

Biointron 2024-01-20 Read time: 3 mins
MAbs.jpg
Image credit: The Wellcome Trust

Monoclonal antibodies (mAbs) are immunoglobulins obtained from single cloned homogeneous hybrid cells (B lymphocyte cells). This is done by fusing spleen cells of an antigen-exposed mouse with human or mouse myeloma cells, then cloning the hybridomas to produce the desired single antibody clone. 

They are used for diagnosis and treatment in various therapeutic areas, including cancer, infectious viral, and bacterial diseases. mAbs can bind to pathogens to reduce their capability to infect new cells, or bind to receptors of microbes, abnormal cells, and proteins, thus preventing escalation of the disease-state and subsequent infections.1 However, mAbs have several pros and cons when being considered for research. 

Pros 

  • Binds with high specificity due to being products of a single clone, and most mAbs do not show cross-reactivity. 

  • Multiple uses (incl. diagnostic assays, therapies) and treats a wide range of conditions. 

  • Hybridoma cells which produce mAbs are perpetual sources of antibodies with the same specificity and sensitivity. 

  • Can be used with or without purification. 

  • Very useful for conjugation to different probes as their homogenous chemical nature can be characterized easily. 

  • Side effects of mAb drugs can be treated through optimization, such as humanization or affinity maturation, or by using antibody fractions.

Cons 

  • More expensive than polyclonal antibodies. 

  • Production requires both in vivo and in vitro systems due to laborious process of producing immortalized hybridoma cell lines. 

  • Skilled and trained workers are essential. 

  • Potential adverse effects when used in therapeutics if human anti-monoclonal antibody (HAMA) response is triggered. 

  • Due to its homogeneity, mAbs are vulnerable to degradation because of the shared susceptibility among all antibody molecules within the solution. 

At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs.  For large-scale applications, our large scale antibody production services ensure consistent, high-quality mAb production tailored to your research or therapeutic goals. Our team of experts provides customized solutions to streamline your workflows and achieve your objectives efficiently. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.


References: 

  1. Singh, A., Chaudhary, S., Agarwal, A., & Verma, A. S. (2014). Antibodies: Monoclonal and Polyclonal. Animal Biotechnology, 265-287. https://doi.org/10.1016/B978-0-12-416002-6.00015-8 

Subscribe to our Blog

Recommended Articles

Biointron’s 2025 Lunch & Learn Antibody Series: “Advancing Antibody Discovery: Innovations, Trends, and Industry Insights”

Biointron’s Lunch & Learn with MassBio was held in Boston, MA, on May 9. The……

May 12, 2025
AACR 2025 – Chicago: Highlights and Event Recap

The AACR Annual Meeting 2025 was held in Chicago, IL from April 25-30, and featu……

May 02, 2025
Biointron vs. Traditional Workflows: A Comparative Perspective

Discovery Speed Traditionally, generating a monoclonal antibody via hybridoma mi……

Apr 29, 2025
How Biointron Stays Ahead with Industry Trends

The antibody therapeutics field is dynamic, with new trends constantly shaping h……

Apr 25, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.